Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
Yiyi Yao, Fenglin Li, Jiansong Huang, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Lymphatic vessels in bone support regeneration after injury
Lincoln Biswas, Junyu Chen, Jessica De Angelis, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 382-397.e24
Open Access | Times Cited: 129
Advances in single-cell RNA sequencing and its applications in cancer research
Dezhi Huang, Naya Ma, Xinlei Li, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 85
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Oncofetal reprogramming in tumour development and progression
Ankur Sharma, Camille Blériot, Jennifer Currenti, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 593-602
Closed Access | Times Cited: 55
The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways
Maryam Bakhtiyari, Mahsa Liaghat, Fatemeh Aziziyan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 31
Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
Xin Liu, Shuxin Zhong, Kangjie Qiu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches
Thomas Menter, Alexandar Tzankov
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions
Luca Guarnera, Enrico Santinelli, Elisa Galossi, et al.
Experimental Hematology (2023) Vol. 129, pp. 104118-104118
Closed Access | Times Cited: 17
Y‐box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts—implications for acute myeloid leukaemia
Venkatesh Kumar Chetty, Jamal Ghanam, Kristína Lichá, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 6
The critical role of the bone marrow stromal microenvironment for the development of drug screening platforms in leukemia
Rhiannon G. Panting, Rishi S. Kotecha, Laurence C. Cheung
Experimental Hematology (2024) Vol. 133, pp. 104212-104212
Open Access | Times Cited: 5
A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
Başak Aru, Cemil Pehlivanoğlu, Zeynep Dal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Consequences of Aging on Bone
Lingli Zhang, Qiao Guan, Zhikun Wang, et al.
Aging and Disease (2023)
Open Access | Times Cited: 13
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
Yáiza Núñez, Annabel García‐León, Aïda Falgàs, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 727-727
Open Access | Times Cited: 11
Bone Marrow Endothelial Progenitor Cells remodelling facilitates normal hematopoiesis during Acute Myeloid Leukemia Complete Remission
Tong Xing, Lijuan Hu, Hongyan Zhao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
LncRNA SNHG5 induces CAFs-like phenotype and autophagy of AML-MSCs via PTBP1/ATG5 axis to confer chemoresistance of AML cells
Yuan Song, Lili Hu, Jing Cheng, et al.
Cellular Signalling (2025), pp. 111625-111625
Closed Access
Sonidegib Inhibits the Adhesion of Acute Myeloid Leukemia to the Bone Marrow in Hypoxia: An Optical Tweezer Study
Katarzyna Gdesz-Birula, Sławomir Drobczyński, Krystian Sarat, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 578-578
Open Access
Expression patterns, prognostic significance, and immune correlations of the TNFAIP8 family in acute myeloid leukemia: a comprehensive bioinformatics analysis
Xuezhong Zhang, Min Qu, Lei Bi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Prognosis of different types of acute infection in the first episode of childhood acute leukemia
Shasha Li, Shanshan Li, Yi Chen, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Signaling pathways governing the behaviors of leukemia stem cells
Shirin Azizidoost, Ava Nasrolahi, Mohadeseh Sheykhi-Sabzehpoush, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 830-846
Open Access | Times Cited: 9
Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia
Shu-Qian Tang, Tong Xing, Zhong‐Shi Lyu, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2553-2570
Closed Access | Times Cited: 9
The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis
Negar Noorbakhsh, Bentolhoda Hayatmoghadam, Marzieh Jamali, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Acute myeloid leukemia: therapeutic targeting of stem cells
Cindy M. Pabon, Hussein A. Abbas, Marina Konopleva
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 6, pp. 547-556
Closed Access | Times Cited: 13
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
Sam Humphries, Danielle R. Bond, Zacary P. Germon, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy
Xinai Liao, Danni Cai, Jingru Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 8
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Catana Allert, Alexander Waclawiczek, Sarah Miriam Naomi Zimmermann, et al.
Leukemia (2022) Vol. 36, Iss. 10, pp. 2418-2429
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top